Embecta Corp. (EMBC) stock
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.43−0.10 (-1.53%)
Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%
Embecta ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Embecta's ebitda for the twelve months ending Jun 30, 2026 was $267.70M, up 7.6% year over year. For fiscal 2025 it was $282.80M, up 39.3% from the year before. The highest annual figure on record is $530.30M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $282.80M | +39.3% |
| FY2024 | Sep 30, 2024 | $203.00M | -20.1% |
| FY2023 | Sep 30, 2023 | $254.10M | -25.5% |
| FY2022 | Sep 30, 2022 | $341.30M | -35.6% |
| FY2021 | Sep 30, 2021 | $530.30M | +1.0% |
| FY2020 | Sep 30, 2020 | $524.80M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $59.30M | -42.5% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $45.20M | -37.1% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $93.60M | +145.7% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $69.60M | +95.0% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $103.20M | +59.3% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $71.90M | +49.2% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $38.10M | -29.8% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $35.70M | +1.7% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $64.80M | +9.1% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $48.20M | -24.2% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $54.30M | -43.4% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $35.10M | +680.0% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $59.40M | -44.1% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $63.60M | -39.8% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $96.00M | -23.2% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $4.50M | -96.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $106.20M | -20.9% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $105.60M | -22.7% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $125.00M | -6.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $126.10M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $134.20M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $136.60M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $133.40M | – |
See a number that looks wrong?